Insmed
INSM
#906
Rank
NZ$46.92 B
Marketcap
NZ$214.88
Share price
0.71%
Change (1 day)
-11.91%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -NZ$1.88 Billion

According to Insmed's latest financial reports the company's current earnings are NZ$0.81 Billion. In 2025 the company made an earning of -NZ$2.08 Billion a decrease over its 2024 earnings that were of -NZ$1.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$1.88 Billion-9.68%
2025 -NZ$2.08 Billion43.91%
2024 -NZ$1.45 Billion23.71%
2023 -NZ$1.17 Billion45.77%
2022 -NZ$0.81 Billion15.83%
2021 -NZ$0.7 Billion50.19%
2020 -NZ$0.47 Billion16.4%
2019 -NZ$0.4 Billion-23.9%
2018 -NZ$0.52 Billion59.35%
2017 -NZ$0.33 Billion8.52%
2016 -NZ$0.31 Billion47.25%
2015 -NZ$0.21 Billion34.53%
2014 -NZ$0.16 Billion58.83%
2013 -NZ$95.54 Million35.14%
2012 -NZ$70.7 Million-31.92%
2011 -NZ$0.11 Billion854.92%
2010 -NZ$10.88 Million-105.22%
2009 NZ$0.20 B-905.06%
2008 -NZ$25.87 Million-27.31%
2007 -NZ$35.58 Million-62.41%
2006 -NZ$94.65 Million98.19%
2005 -NZ$47.76 Million0.03%
2004 -NZ$47.74 Million159.07%
2003 -NZ$18.43 Million-69.31%
2002 -NZ$60.04 Million
2000 -NZ$54.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$27.47 B-1,532.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
NZ$18.67 B-1,073.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$8.81 B-559.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$42.58 M-102.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-NZ$40.46 Million-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-NZ$40.93 Million-97.87%๐Ÿ‡บ๐Ÿ‡ธ USA